Jim Cramer on NVIDIA: “There Would Be No AI Revolution Without Jensen Huang”
By Maksym Misichenko · Yahoo Finance ·
By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panelists agreed that NVDA's valuation is risky due to assumptions about earnings growth and the cyclical nature of semiconductor CapEx. They also highlighted the potential risk of a 'sovereign AI' spending plateau and the shift toward custom silicon by hyperscalers. The panelists had differing views on the potential impact of TSMC's CoWoS capacity constraints.
Risk: The 'sovereign AI' spending plateau and the shift toward custom silicon by hyperscalers
Opportunity: None explicitly stated
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
NVIDIA Corporation (NASDAQ:NVDA) was among Jim Cramer’s Mad Money stock calls as he urged investors to exercise caution when it comes to red-hot AI stocks. Cramer commented on the company’s valuation, as he said:
How about NVIDIA? Look, it’s finally moving, up… 4.4% today. Good reason. There’s a very good chance that, based on forward earnings estimates, NVIDIA’s stock is now cheaper than the average stock in the S&P 500… Now that’s absurd. The company’s growing at a much faster pace than almost any large-cap enterprise, and it sells below… S&P market multiple. Now that’s crazy… There would be no AI revolution without Jensen Huang and NVIDIA. The company practically invented artificial intelligence as we know it and married it with accelerated computing to give us trillions of dollars’ worth of gains. Now, we’re faced with the real test, which is whether the biggest market outside the United States, China, will be reopened to them.
Photo by Javier Esteban on Unsplash
NVIDIA Corporation (NASDAQ:NVDA) develops accelerated computing and AI platforms, GPUs for gaming and professional use, cloud services, robotics and embedded systems, and automotive technologies.
While we acknowledge the potential of NVDA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years** **
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"NVDA's valuation appears attractive only if one assumes current hyper-growth rates are sustainable, ignoring the rising threat of custom silicon adoption by major cloud service providers."
Cramer’s valuation argument hinges on a forward P/E compression that assumes earnings growth remains linear, ignoring the cyclical nature of semiconductor CapEx. While NVDA’s dominance is undeniable, the 'cheaper than the S&P' narrative is dangerous; it treats AI-driven hyper-growth as a permanent baseline rather than a potential peak. The real risk isn't just China—it's the 'sovereign AI' spending plateau and the inevitable shift toward custom silicon (ASICs) by hyperscalers like Google and Amazon. If NVDA’s margins compress as competitors scale their own internal chips, the current valuation isn't 'cheap'—it’s a value trap masking a transition from a monopoly to a competitive market.
If NVDA maintains its software moat via CUDA and continues to iterate on Blackwell and Rubin architectures faster than competitors can catch up, the current valuation could indeed represent a massive discount on long-term cash flows.
"N/A"
[Unavailable]
"NVDA's valuation cheapness relative to growth is real, but the article mistakes price-to-growth attractiveness for investment merit without addressing whether the growth assumptions themselves are at risk from geopolitical or capex-cycle headwinds."
Cramer's valuation argument—NVDA trading below S&P 500 forward multiples despite 30%+ EPS growth—is arithmetically sound and worth taking seriously. But the article conflates two separate claims: (1) NVDA is cheap relative to growth, and (2) NVDA is a buy. The first doesn't guarantee the second. The real test Cramer identifies—China market access—is binary and geopolitical, not fundamentally driven. If Trump's tariff/decoupling agenda hardens, NVDA's TAM shrinks materially regardless of valuation. The article also omits that NVDA's forward multiples compression may reflect genuine uncertainty about AI capex sustainability post-2025, not just a bargain.
NVDA's sub-market multiple could be rational if consensus EPS estimates are too optimistic or if AI capex cycles are front-loaded; the China question alone could justify a 20-30% valuation discount if reopening odds are <50%.
"NVIDIA's high valuation combined with regulatory and cyclical AI demand risk creates asymmetric downside if AI adoption slows or export controls tighten, making the stock vulnerable to multiple compression."
While the article leans into Nvidia’s AI leadership, the strongest counter is that the rally rests on optimistic growth assumptions and a cyclical AI capex tailwind that may fade. Valuation remains rich relative to visible growth, and any moderation in cloud/hyperscale spend could compress earnings. Regulatory risk is nontrivial: ongoing export controls on advanced GPUs to China could cap revenue growth or shift mix away from a large international portion of Nvidia’s business. Competition from AMD/Intel and potential architecture shifts could erode the hardware moat, while supply-chain and energy costs add fragility. In short, the upside may be capped if AI demand softens or policy tightens.
On the other hand, if AI compute demand remains robust and restrictions stay contained, Nvidia could keep outperforming and sustain a premium multiple. The ecosystem effects (CUDA software, developer adoption) create stickiness that could sustain earnings even with modest revenue growth.
"NVDA's valuation reflects a supply-constrained reality where physical packaging bottlenecks, not just demand, dictate the ceiling for revenue growth."
Gemini’s 'sovereign AI' plateau theory is the most critical risk, yet everyone is ignoring the supply-side constraint: TSMC's CoWoS capacity. Even if demand remains, NVDA’s growth is physically capped by packaging bottlenecks through 2025. If hyperscalers shift to custom ASICs, they aren't just competing with NVDA; they are competing for the same limited wafer starts. This creates a zero-sum game where NVDA's margins might actually expand due to scarcity, even as their total market share faces long-term structural erosion.
[Unavailable]
"TSMC's CoWoS expansion may render the supply constraint moot unless AI capex demand collapses first—and that's the real tail risk."
Gemini's CoWoS bottleneck is real, but the logic inverts: scarcity doesn't expand NVDA margins if they can't fulfill orders. The zero-sum wafer fight assumes TSMC capacity is fixed—it isn't. TSMC is expanding CoWoS aggressively through 2025-26. The actual risk is demand destruction if hyperscalers hit ROI walls on AI capex before capacity constraints bite. That's the sequencing nobody's addressing: does demand plateau before supply does?
"The sequencing risk is the real limiter: CoWoS supply may rise, but if AI capex demand rolls over before it fully ramps, NVDA margins won't sustain."
Gemini's CoWoS bottleneck framing risks overestimating margin upside. Even with TSMC capacity growth, the real hinge is AI capex ROI: if hyperscalers hit ROI walls, demand could roll over before CoWoS ramps, digesting pricing power and squeezing margins. The sequencing matters: a supply rise without durable demand is just excess capacity, not a sustainability story. Also watch for alternative silicon and software moat erosion that cap the upside.
The panelists agreed that NVDA's valuation is risky due to assumptions about earnings growth and the cyclical nature of semiconductor CapEx. They also highlighted the potential risk of a 'sovereign AI' spending plateau and the shift toward custom silicon by hyperscalers. The panelists had differing views on the potential impact of TSMC's CoWoS capacity constraints.
None explicitly stated
The 'sovereign AI' spending plateau and the shift toward custom silicon by hyperscalers